|Table of Contents|

Clinical and pathological features of 5 cases of uterine inflammatory myofibroblastic tumor

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2023 03
Page:
493-496
Research Field:
Publishing date:

Info

Title:
Clinical and pathological features of 5 cases of uterine inflammatory myofibroblastic tumor
Author(s):
GUO Xingdan1LIN Chunhua1ZHOU Zhijiao2TANG Mi1CHEN Min1SANG Na1LIU Shiwei1TAN Ting1ZOU Qiong2
1.Department of Pathology,Hunan Maternity and Infant Hospital,Hunan Changsha 410028,China;2.Department of Pathology,the Third Xiangya Hospital,Central South University,Hunan Changsha 410003,China.
Keywords:
uterine neoplasminflammatory myofibroblastic tumorALKimmunohistochemistryFISH
PACS:
R737.33
DOI:
10.3969/j.issn.1672-4992.2023.03.020
Abstract:
Objective:To explore the clinicopathologic features and differential diagnosis of uterine inflammatory myofibroblastic tumor(UIMT).Methods:Five UIMT cases were analyzed for their clinical and pathologic features,and relevant literature was reviewed.Results:The age of the five patients ranged from 23 to 49 years.The initial diagnosis were considered as uterine smooth muscle tumor.The tumors were intramural or submucosal in location,with a medium or slightly fine texture and a mucus sensation.Histologically,the cases were mainly myxoid pattern.Spindle cells are sparsely arranged in myxoid stroma,and in some areas,dense spindle cells are arranged in bundles,similar to leiomyomas.Atypia of tumor cells were mild,with rare mitoses and infiltration of inflammatory cells.Two tumors had infiltrated the adjacent tissues.All the five tumors were ALK-positive with granular cytoplasmic staining by immunohistochemistry.ALK gene rearrangements were detected by fluorescence in situ hybridization(FISH) in five tumors.No metastases and recurrences were found in the postoperative follow-up.Conclusion:The clinical and pathological features of UIMT overlap with those of smooth muscle tumors and endometrial stromal tumors.It is recommended that the diagnosis of UIMT should be combined with histomorphology,ALK immunohistochemistry and FISH detection to avoid misdiagnosis and missed diagnosis.

References:

[1]谢军伟,毛宇强,王京利,等.炎性肌纤维母细胞瘤诊断和治疗的研究进展[J].现代肿瘤医学,2019,27(21):3927-3930. XIE JW,MAO YQ,WANG JL,et al.The progression of inflammatory myofibroblastic tumor in the diagnosis and treatment[J].Modern Oncology,2019,27(21):3927-3930.
[2] 刘杰,李葱,高英,等.乳腺炎性肌纤维母细胞瘤的研究进展[J].现代肿瘤医学,2019,27(14):2601-2604. LIU J,LI C,GAO Y,et al.Research progress of inflammatory myofibroblastic tumor of breast[J].Modern Oncology,2019,27(14):2601-2604.
[3] COFFIN CM,PATEL A,PERKINS S,et al.ALK1 and p80 expression and chromosomal rearrangements involving 2p23 in inflammatory myofibroblastic tumor[J].Mod Pathol,2001,14(6):569-576.
[4] SHUKLA PS,MITTAL K.Inflammatory myofibroblastic tumor in female genital tract[J].Arch Pathol Lab Med,2019,143(1):122-129.
[5] COFFIN CM,WATTERSON J,PRIEST JR,et al.Extrapulmonary inflammatory myofibroblastic tumor(inflammatory pseudotumor).A clinicopathologic and immunohistochemical study of 84 cases[J].Am J Surg Pathol,1995,19(8):859-872.
[6] PARRA-HERRAN C,QUICK CM,HOWITT BE,et al.Inflammatory myofibroblastic tumor of the uterus:clinical and pathologic review of 10 cases including a subset with aggressive clinical course[J].Am J Surg Pathol,2015,39(2):157-168.
[7] MOHAMMAD N,HAIMES JD,MISHKIN S,et al.ALK is a specific diagnostic marker for inflammatory myofibroblastic tumor of the uterus[J].Am J Surg Pathol,2018,42(10):1353-1359.
[8] COOK JR,DEHNER LP,COLLINS MH,et al.Anaplastic lymphoma kinase(ALK) expression in the inflammatory myofibroblastic tumor:A comparative immunobistochemical study[J].Am J Surg Pathol,2001,25(11):1364-1371.
[9] SCHAEFER IM,HORNICK JL,SHOLL LM,et al.Abnormal p53 and p16 staining patterns distinguish uterine leiomyosarcoma from inflammatory myofibroblastic tumour[J].Histopathology,2017,70(7):1138-1146.
[10] 张瑜,董伟,李淑霞,等.子宫炎性肌纤维母细胞肿瘤临床及分子病理学特征[J].中华病理学杂志,2021,50(9):1020-1023. ZHANG Y,DONG W,LI SX,et al.Clinical and molecular pathological features of uterine inflammatory myofibroblastic tumor[J].Chinese Journal of Pathology,2021,50(9):1020-1023.
[11] PREOBRAZHENSKAYA EV,IYEVLEVA AG,SULEYMANOVA AM,et al.Gene rearrangements in consecutive series of pediatric inflammatory myofibroblastic tumors[J].Pediatr Blood Cancer,2020,67(5):e28220.
[12] CHIANG S.Recent advances in smooth muscle tumors with PGR and PLAG1 gene fusions and myofibroblastic uterine neoplasms[J].Genes Chromosomes Cancer,2021,60(3):138-146.
[13] HAIMES JD,STEWART CJR,KUDLOW BA,et al.Uterine inflammatory myofibroblastic tumors frequently harbor ALK fusions with IGFBP5 and THBS1[J].Am J Surg Pathol,2017,41(6):773-780.
[14] PICKETT JL,CHOU A,ANDRICI JA,et al.Inflammatory myofibroblastic tumors of the female genital tract are under-recognized:a low threshold for ALK immunohistochemistry is required[J].Am J Surg Pathol,2017,41(10):1433-1442.
[15] DALTON BG,THOMAS PG,SHARP NE,et al.Inflammatory myofibroblastic tumors in children[J].J Pediatr Surg,2016,51(4):541-544.
[16] BENNETT JA,NARDI V,ROUZBAHMAN M,et al.Inflammatory myofibroblastic tumor of the uterus:a clinicopathological,immunohistochemical,and molecular analysis of 13 cases highlighting their broad morphologic spectrum[J].Mod Pathol,2017,30(10):1489-1503.
[17] VILLALOBOS VM,CAMIDGE DR.Targeting ALK in inflammatory myofibroblastic tumours[J].Lancet Respir Med,2018,6(6):405-407.
[18] THEILEN TM,SOERENSEN J,BOCHENNEK K,et al.Crizotinib in ALK+ inflammatory myofibroblastic tumors-current experience and future perspectives[J].Pediatr Blood Cancer,2018,65(4):e26920.

Memo

Memo:
湖南省卫生健康委科研计划项目(编号:202101042125)
Last Update: 2022-12-30